{"article": [{"url": "https://www.marketwatch.com/story/metacrines-stock-debuts-with-an-11-gain-above-its-ipo-price-2020-09-16", "published": 1600256600.0, "headline": "Metacrine's stock debuts with an 11% gain above its IPO price", "body": "Shares of Metacrine Inc. MTCR, +2.10% got a bullish start to their public life, as they opened 10.7% their initial public offering price. The IPO priced overnight at $13 a share, in the middle of the expected range of $12 to $14. The stock's first trade was at $14.39 at 11:31 a.m. Eastern for 176,545 shares. It has since pared some gains to trade up 7.6%. The San Diego-based biopharmaceutical company went public during a busy week for IPOs, which includes the debut of Snowflake Inc. SNOW, -0.91%, the biggest-ever software IPO. Despite the growing IPO supply, there is still strong demand from investors, as the Renaissance IPO ETF IPO, +1.98% has run up 25.8% over the past three months while the S&P 500 SPX, +0.87% has gained 9.5%."}]}